Stansberry Asset Management, LLC Bristol Myers Squibb CO Call Options Transaction History

Stansberry Asset Management, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $29.7 Million - $32.9 Million	-666,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $30.1 Million - $35.8 Million	666,100 New	666,100 $31.5 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stansberry Asset Management, LLC with notifications on news.